tiprankstipranks
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market
Holding YMAB?
Track your performance easily

Y-Mabs Therapeutics (YMAB) Technical Analysis

211 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Y-Mabs Therapeutics’s (YMAB) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting Y-Mabs Therapeutics is a Sell.
Y-Mabs Therapeutics’s (YMAB) 20-Day exponential moving average is 11.89, while Y-Mabs Therapeutics’s (YMAB) share price is $12.98, making it a Buy.
Y-Mabs Therapeutics’s (YMAB) 50-Day exponential moving average is 12.47, while Y-Mabs Therapeutics’s (YMAB) share price is $12.98, making it a Sell.

Y-Mabs Therapeutics (YMAB) Pivot Points

Nov 20, 2024, 01:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.17
11.45
11.76
12.04
12.35
12.63
12.94
Fibonacci
11.45
11.68
11.81
12.04
12.27
12.40
12.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Y-Mabs Therapeutics (YMAB) Moving Averages

Nov 20, 2024, 01:20 PM
Period
Simple
Exponential
MA5
11.73Buy
11.93Buy
MA10
11.67Buy
11.82Buy
MA20
11.84Buy
11.89Buy
MA50
12.56Sell
12.47Sell
MA100
14.13Sell
12.56Sell
MA200
10.82Buy
10.39Buy
Y-Mabs Therapeutics’s (YMAB) 10-Day exponential moving average is 11.82, while Y-Mabs Therapeutics’s (YMAB) share price is $12.98, making it a Buy.
Y-Mabs Therapeutics’s (YMAB) 100-Day exponential moving average is 12.56, while Y-Mabs Therapeutics’s (YMAB) share price is $12.98, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) stock price is $12.98 and Y-Mabs Therapeutics’s (YMAB) 50-day simple moving average is 12.56, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $12.98 and Y-Mabs Therapeutics’s (YMAB) 100-day simple moving average is 14.13, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $12.98 and Y-Mabs Therapeutics’s (YMAB) 200-day simple moving average is 10.82, creating a Buy signal.

Y-Mabs Therapeutics (YMAB) Technical Indicators

Nov 20, 2024, 01:20 PM
Name
Value
Implied Action
RSI (14)
57.26
Neutral
STOCH (9,6)
50.30
Neutral
STOCHRSI (14)
50.30
Neutral
MACD (12,26)
-0.18
Sell
ADX (14)
11.90
Buy
Williams %R
-32.44
Buy
CCI (14)
174.94
Sell
ATR (14)
0.64
-
Ultimate Oscillator
51.28
Neutral
ROC
3.92
Buy
Y-Mabs Therapeutics’s (YMAB) Relative Strength Index (RSI) is 57.26, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Trend Strength Indicator (ADX) is 11.90, creating a Buy signal.
Y-Mabs Therapeutics’s (YMAB) Commodity Channel Index (CCI) is 174.94, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) Price Rate of Change (ROC) is 3.92, creating a Buy signal.

FAQ

Is YMAB a Buy, Hold, or Sell?
Based on YMAB’s technical indicators, YMAB is a Buy.
    What is YMAB’s RSI (14)?
    YMAB’s RSI (14) is 57.26, which suggests YMAB is a Neutral.
      What is YMAB’s MACD?
      YMAB’s MACD is -0.18, which suggests YMAB is a Sell.
        What is YMAB’s 5-day moving average?
        YMAB’s 5-day moving average is 11.73, which suggests YMAB is a Buy.
          What is YMAB’s 20-day moving average?
          YMAB 20-day moving average is 11.84, which suggests YMAB is a Buy.
            What is YMAB’s 50-day moving average?
            YMAB’s 50-day moving average is 12.56, which suggests YMAB is a Sell.
              What is YMAB’s 200-day moving average?
              YMAB’s 200-day moving average is 10.82, which suggests YMAB is a Buy.
                What is YMAB’s Williams % R (14)?
                YMAB’s Williams % R (14) is -32.44, which suggests YMAB is a Buy.
                  What is YMAB’s CCI (14)?
                  YMAB’s CCI (14) is 174.94, which suggests YMAB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis